Phase 1b Study in Patients With Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)
Status:
Recruiting
Trial end date:
2021-09-15
Target enrollment:
Participant gender:
Summary
This exploratory open-label phase 1b, ascending dose study is to evaluate the effects of
psilocybin on cognition in patients with Chronic Short-Lasting Unilateral Neuralgiform
Headache Attacks (SUNHA)